With the development of comprehensive molecular profiling of NSCLC, an increasing number of uncommon EGFR mutations have been revealed other than the known EGFR-sensitive mutations, including EGFR exon 19 deletion and the exon 21 L858R missense mutation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.